NCT06300996View on ClinicalTrials.gov

Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb

NAActive, not recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2029

Conditions
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type IISpinal Muscular Atrophy 4SMA
Interventions
DEVICE

Spinal Cord Stimulator (Octopolar Medtronic Vectris Leads)

Spinal cord stimulation is FDA approved for treatment of pain. We are proposing utilizing the same technology to help restore motor control in people who have declining function due to the progression of SMA. These are 2-4 leads that are FDA-approved.

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

Roche-Genentech

INDUSTRY

lead

Marco Capogrosso

OTHER